Today on Pharmaceutical Processing
Resilience, Lilly invest $750M in pharma, KwikPen manufacturing
Resilience announced today that it expanded its strategic partnership with Eli Lilly (NYSE:LLY) to increase medicine production in the U.S. The Cincinnati-based CDMO and the pharmaceutical giant first struck a partnership in 2023. Now, with $750 million invested, the companies are expanding Resilience’s advanced pharmaceutical manufacturing operations in Ohio. Now, Resilience’s production in that region…
OEE is not a hammer, nor is every problem a nail
Consider a common scenario: a pharmaceutical manufacturing plant has identified the equipment most critical to the success of its processes and has begun tracking overall equipment effectiveness (OEE) for those assets. Management has set an ambitious OEE metric of 95% for those critical machines, and operators and technicians are collaborating closely to make sure they…
Sponsored Content See More >
Accelerating pharmaceutical manufacturing digitalization with low-code developmentPharmaceutical manufacturers don’t just need digitalization – they need speed. Traditional MES deployment timelines, often stretching from 8 to 24…
Leading Pharmacy Automation Companies Transforming Health CareThe rising demand for accuracy, efficiency and real-time visibility has made pharmacy automation an integral part of both retail and…
Digital Transformation in the Pharmaceutical IndustryGrundfos Industry Experts A leading global pharmaceutical manufacturing company, ranked among the top 20 worldwide, sought to optimize operational efficiencies…
Raumedic: A Trusted Partner in Serving the Pharmaceutical Industry with the Gold Standard in Silicone TubingRaumedic is a trusted partner in the international medical technology and pharmaceutical industry. The medical division of the global corporation…
Personalized medicine: advanced technology is saving livesThe concept of a “batch size one” in pharmaceutical manufacturing is closer than ever. There are companies advancing cell therapies…
MES for Flexible, Paperless Pharmaceutical ProductionAll companies in the pharmaceutical industry are under pressure for time, quality, compliance, and innovation. These pressures create imperatives to…
Pave the way to high productivity with continuous manufacturing for pharmaContinuous manufacturing in the pharmaceutical industry is increasing as more manufacturers realize the benefits of the technology. But no two…
Revolutionizing Pharma Sustainability: Grundfos Solutions for Optimizing EfficiencyThis white paper highlights the pressing need for sustainability in the pharmaceutical industry, where energy-intensive processes contribute significantly to environmental…
The Evolution of Heat Sealingby Charles H. Trillich / Co-Founder Packworld USA Heat sealing technology has evolved over many decades to reduce cost and…
Difficult transmembrane protein targets for therapeutic antibodiesWhat is the current landscape of antibodies targeting membrane proteins? As of June 2022, 162 antibodies had been approved for…
Validatable Band Sealers for Medical PouchesBy Lynn Miranda, Sales Manager for All Packaging Machinery Corp, Ronkonkoma, NY. The customer’s level of confidence and trust is…
A new way to access scientific papers?Losing university access doesn’t mean losing access to articles anymore By DeepDyve Digital Library Team Many researchers are surprised to…
Regulatory See More >
Fujifilm Biotechnologies selected for FDA PreCheck Pilot Program
A Fujifilm Biotechnologies’ commercial-scale cell culture manufacturing facility has been selected for the FDA’s PreCheck Pilot Program, the company announced. The CDMO’s Holly Springs, North Carolina, facility was selected as one of seven participants in the program designed to strengthen United States pharmaceutical manufacturing capabilities and accelerate patient access to critical medicines. “We are honored…
Learn how to rapidly develop smart and sustainable engineering and production processes See More >
Personalized medicine: advanced technology is saving lives
The concept of a “batch size one” in pharmaceutical manufacturing is closer than ever. There are companies advancing cell therapies in which body cells are used to heal or support the individual patient. These cells are manipulated or edited to change certain biological characteristics before being transferred to the patient. Personalized medicine is truly about…
Facility See More >
Fujifilm Biotechnologies selected for FDA PreCheck Pilot Program
A Fujifilm Biotechnologies’ commercial-scale cell culture manufacturing facility has been selected for the FDA’s PreCheck Pilot Program, the company announced. The CDMO’s Holly Springs, North Carolina, facility was selected as one of seven participants in the program designed to strengthen United States pharmaceutical manufacturing capabilities and accelerate patient access to critical medicines. “We are honored…
Supply Chain See More >
Ratio Therapeutics raises $70M to expand manufacturing infrastructure
Ratio Therapeutics announced today that it closed a $70 million Series C financing to support its radiopharmaceutical development and manufacturing. Existing investors Duquesne Family Office and Bristol Myers Squibb participated. New investors Catalio Capital Management, Eli Lilly and Wasatch Group joined as well. Boston-based Ratio plans to use the proceeds to fund its next phase…
Recalls See More >
Report: Japan health authorities investigate Kobayashi Pharmaceutical factory after five deaths
Japanese health authorities searched a Kobayashi Pharmaceutical factory in Japan following reports of five deaths related to dietary supplements, Reuters reports. The plant inspection in western Japan is the second in recent days as health authorities inspected the company’s Osaka facility. In addition to the five reported deaths, there have been more than 100 hospitalizations…
